Price $63.89 |
Market Cap
3.22B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
46.2
|
P/B
5.34
|
P/S
7.8
|
Dividend %
-
|
|
P/CF
87.2
|
P/FCF
56.9
|
Op. Cash Flow
74.3K
|
FCF
1.0
|
|
Op. Margin
17.10%
|
Net Margin
15.90%
|
ROE
11.40%
|
ROI
11.60%
|
|
ROA
10.40%
|
EPS Growth
24.50%
|
Current Ratio
9.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Horizon Pharma PLC (HZNP) | $27.88 | - | - | 3.5B | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $4.40 | - | - | 79M | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.95 | - | - | 15.1M | Strong Buy |
| Lannett Company, Inc. (LCI) | $7.93 | - | - | 364.2M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $2.15 | - | - | 22.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
